ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Immunocore Holdings PLC

Immunocore Holdings PLC (IMCR)

34.21
-1.23
( -3.47% )
Updated: 13:44:59

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
34.21
Bid
34.22
Ask
34.30
Volume
942,486
33.89 Day's Range 35.405
0.00 52 Week Range 0.00
Market Cap
Previous Close
35.44
Open
35.01
Last Trade
11
@
34.255
Last Trade Time
13:45:03
Financial Volume
$ 32,327,454
VWAP
34.3002
Average Volume (3m)
-
Shares Outstanding
48,088,346
Dividend Yield
-
PE Ratio
-29.88
Earnings Per Share (EPS)
-1.15
Revenue
249.43M
Net Profit
-55.29M

About Immunocore Holdings PLC

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority o... Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States. Show more

Sector
Noncomml Resh Organizations
Industry
Noncomml Resh Organizations
Headquarters
Oxfordshire, Gbr
Founded
1970
Immunocore Holdings PLC is listed in the Noncomml Resh Organizations sector of the NASDAQ with ticker IMCR. The last closing price for Immunocore was $35.44. Over the last year, Immunocore shares have traded in a share price range of $ 0.00 to $ 0.00.

Immunocore currently has 48,088,346 shares outstanding. The market capitalization of Immunocore is $1.65 billion. Immunocore has a price to earnings ratio (PE ratio) of -29.88.

IMCR Latest News

Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma

Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous...

Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response

Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response Data were...

Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024

Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024 Monotherapy...

Immunocore to present at the Jefferies Global Healthcare Conference

Immunocore to present at the Jefferies Global Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 30 May 2024) Immunocore Holdings plc (Nasdaq: IMCR...

Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma

Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma Following recent consultation with...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WENAANEW MEDICAL INC
$ 3.91
(136.97%)
79.33M
OPTXSyntec Optics Holdings Inc
$ 4.5812
(94.94%)
31.34M
FFIEFaraday Future Intelligent Electric Inc
$ 0.47
(77.36%)
546.62M
CMAXCareMax Inc
$ 3.281
(72.68%)
7.01M
AIEVThunder Power Holdings Inc
$ 2.3585
(37.12%)
29.17M
CNSPCNS Pharmaceuticals Inc
$ 1.77
(-37.68%)
1.34M
GRIGRI Bio Inc
$ 1.87
(-37.04%)
629.25k
NUWENewellis Inc
$ 0.14195
(-34.83%)
9.78M
LYELLyell Immunopharma Inc
$ 1.345
(-34.07%)
8.9M
BJDXBluejay Diagnostics Inc
$ 1.86
(-32.36%)
2.02M
FFIEFaraday Future Intelligent Electric Inc
$ 0.47
(77.36%)
546.62M
NVDANVIDIA Corporation
$ 123.855
(-1.77%)
241.22M
RIVNRivian Automotive Inc
$ 14.3859
(20.28%)
205.51M
WENAANEW MEDICAL INC
$ 3.91
(136.97%)
79.33M
SQQQProShares UltraPro Short QQQ
$ 8.2305
(-1.90%)
75.41M